| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $476.0M | +3.7% |
| Cost of Revenue | $335.4M | -5.0% |
| Gross Profit | $140.5M | +32.8% |
| R&D Expense | $20.1M | +3.1% |
| SG&A Expense | $37.4M | -7.4% |
| Operating Income | $81.6M | +84.4% |
| Interest Expense | $12.6M | -26.2% |
| Pre-tax Income | $70.2M | +158.0% |
| Income Tax | $922K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $55.3M | +142.8% |
| Accounts Receivable | $69.0M | +3.0% |
| Inventory | $93.9M | +10.5% |
| Current Assets | $254.3M | +23.8% |
| Total Assets | $328.2M | +15.4% |
| Current Liabilities | $227.6M | -8.4% |
| Long-term Debt | $38K | -79.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $62.4M | -11.5% |
| Capital Expenditures | $4.6M | -9.5% |
| Investing Cash Flow | -$4.6M | +9.2% |
| Financing Cash Flow | -$25.9M | +61.2% |
| Free Cash Flow | $57.8M | -11.7% |
| +2.4% |
| Net Income | $69.3M | +163.4% |
| EPS (Basic) | $3.01 | +161.7% |
| EPS (Diluted) | $3.01 | +161.7% |
| Total Liabilities |
| $262.9M |
| -8.8% |
| Stockholders' Equity | $65.3M | +1765.8% |